Volume 22, Issue 2 (12-2025)
ASWTR 2025, 22(2): 10-23 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Naderi M S, Khosravi S, Hemmati P, Ghasemi S, Rasaee Z. Review Study on the Effects of Phototherapy and Low-Level Laser Light in the Treatment of Depressive Disorders. ASWTR 2025; 22 (2) :10-23
URL: http://icml.ir/article-1-670-en.html
URL: http://icml.ir/article-1-670-en.html
Department of Biology, NT.C., Islamic Azad University, Tehran, Iran
Abstract: (21 Views)
Introduction: Psychiatric disorders are mental health conditions characterized by behavioral or cognitive patterns that lead to significant distress or functional impairment. Among these, depression is a prevalent and debilitating disorder, posing a major challenge to global health. Various treatment approaches have been developed, with light-based therapies, including phototherapy and low-level laser therapy (LLLT), emerging as promising interventions.
Methods: This review systematically examines studies published over the past decade retrieved from databases such as Google Scholar, ScienceDirect, PubMed, and Elsevier. The article highlights the clinical features of depression and evaluates different therapeutic strategies, emphasizing the cellular and molecular mechanisms underlying the effects of light and laser therapy.
Results: Evidence suggests that LLLT may modulate neurobiological pathways associated with depressive symptoms, providing a potential non-invasive treatment option.
Conclusions: This review aims to provide an integrated understanding of the therapeutic potential of phototherapy and low-level laser interventions in depression management, offering insights for future research and clinical applications.
Methods: This review systematically examines studies published over the past decade retrieved from databases such as Google Scholar, ScienceDirect, PubMed, and Elsevier. The article highlights the clinical features of depression and evaluates different therapeutic strategies, emphasizing the cellular and molecular mechanisms underlying the effects of light and laser therapy.
Results: Evidence suggests that LLLT may modulate neurobiological pathways associated with depressive symptoms, providing a potential non-invasive treatment option.
Conclusions: This review aims to provide an integrated understanding of the therapeutic potential of phototherapy and low-level laser interventions in depression management, offering insights for future research and clinical applications.
Educational: Review |
Subject:
General
Received: 2025/05/28 | Accepted: 2025/12/14 | Published: 2025/12/14
Received: 2025/05/28 | Accepted: 2025/12/14 | Published: 2025/12/14
References
1. Nigussie K, Tesfaye D, Bete T, Asfaw HJFiPH. Perceived stigma, common mental disorders and associated factors among primary caregivers of adult patients with mental illness attending at public hospitals, Harari regional state, Eastern Ethiopia: A multicenter cross-sectional study. 2023;11:1024228. [DOI:10.3389/fpubh.2023.1024228] [PMID] []
2. Cedrone F, Berselli N, Stacchini L, De Nicolo V, Caminiti M, Ancona A, et al. Depressive Symptoms of Public Health Medical Residents during the COVID-19 Pandemic, a Nation-Wide Survey: The PHRASI Study. Int J Environ Res Public Health. 2023;20(9):5620. [DOI:10.3390/ijerph20095620] [PMID] []
3. Chodavadia P, Teo I, Poremski D, Fung DSS, Finkelstein EAJBp. Prevalence and economic burden of depression and anxiety symptoms among Singaporean adults: results from a 2022 web panel. 2023;23(1):104. [DOI:10.1186/s12888-023-04581-7] [PMID] []
4. Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17(3):327-35. [DOI:10.31887/DCNS.2015.17.3/bbandelow] [PMID] []
5. Paroya S, Lipovsky C, Romano A, Chaturvedi R, Kohol J, Bullock TJUW. The Highs and Lows of Bipolar Disorder. 2022.
6. Duarte AC, Scrandis DA. Diagnostic considerations in identifying bipolar disorder in primary care. Nurse Pract. 2023;48(5):7-10. [DOI:10.1097/01.NPR.0000000000000054] [PMID]
7. Ashokumar SJIIlJM, Human. Post Traumatic Stress Disorder. 2023;6:1896.
8. Torrico TJ, Mikes BA. Posttraumatic Stress Disorder in Children. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Beverly Mikes declares no relevant financial relationships with ineligible companies.: StatPearls Publishing; 2025.
9. Fariba KA, Gupta V. Posttraumatic Stress Disorder in Children. 2020.
10. Fleischhacker WW, Arango C, Arteel P, Barnes TR, Carpenter W, Duckworth K, et al. Schizophrenia-time to commit to policy change. 2014;40(Suppl_3):S165-S94. [DOI:10.1093/schbul/sbu006] [PMID] []
11. Galderisi S, Kaur D, Kéri P, Lennox B, Marder SR, McDaid D, et al. Schizophrenia-Time to Commit to Policy Change. 2024. [DOI:10.2139/ssrn.4703933]
12. Qian J, Hu Q, Wan Y, Li T, Wu M, Ren Z, et al. Prevalence of eating disorders in the general population: a systematic review. Shanghai Arch Psychiatry. 2013;25(4):212-23.
13. Ward ZJ, Rodriguez P, Wright DR, Austin SB, Long MW. Estimation of Eating Disorders Prevalence by Age and Associations With Mortality in a Simulated Nationally Representative US Cohort. JAMA Netw Open. 2019;2(10):e1912925. [DOI:10.1001/jamanetworkopen.2019.12925] [PMID] []
14. Griffiths S, Mond JM, Murray SB, Touyz S. The prevalence and adverse associations of stigmatization in people with eating disorders. Int J Eat Disord. 2015;48(6):767-74. [DOI:10.1002/eat.22353] [PMID]
15. Ebikabowei MJCIJoP. Psychological and Socio-economic Instigators and Manifestations of Conduct Disorder among Secondary School Students in Ekeremor LGA, Bayelsa State, Nigeria. 2021.
16. Tamuno-opubo AT, Adedolapo SH, Akinyemi AR, Ashi AF, Bankole RA, Benjamin OJESiSS. Case report on Assessment and Management of Conduct Disorder of a 12-year-old. 2023;4(1):41-53.
17. Theodoratou M. Communication issues in co-occurring ADHD and autism spectrum disorders. Evaluative approaches and targeted interventions: mini review. Postep Psychiatr Neurol. 2024;33(3):188-95. [DOI:10.5114/ppn.2024.145214] [PMID] []
18. Antshel KM, Russo N. Autism Spectrum Disorders and ADHD: Overlapping Phenomenology, Diagnostic Issues, and Treatment Considerations. Curr Psychiatry Rep. 2019;21(5):34. [DOI:10.1007/s11920-019-1020-5] [PMID]
19. Francés L, Quintero J, Fernández A, Ruiz A, Caules J, Fillon G, et al. Current state of knowledge on the prevalence of neurodevelopmental disorders in childhood according to the DSM-5: a systematic review in accordance with the PRISMA criteria. 2022;16(1):27. [DOI:10.1186/s13034-022-00462-1] [PMID] []
20. Zhang X, Yan Y, Ye Z, Xie JJBp. Descriptive analysis of depression among adolescents in Huangshi, China. 2023;23(1):176. [DOI:10.1186/s12888-023-04682-3] [PMID] []
21. Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, et al. Major depressive disorder. Nat Rev Dis Primers. 2016;2(1):16065. [DOI:10.1038/nrdp.2016.65] [PMID]
22. Marx W, Penninx BW, Solmi M, Furukawa TA, Firth J, Carvalho AF, et al. Major depressive disorder. 2023;9(1):44. [DOI:10.1038/s41572-023-00454-1] [PMID]
23. Gutiérrez-Rojas L, Porras-Segovia A, Dunne H, Andrade-González N, Cervilla JAJBJoP. Prevalence and correlates of major depressive disorder: a systematic review. 2020;42:657-72. [DOI:10.1590/1516-4446-2020-0650] [PMID] []
24. Bains N, Abdijadid S. Major depressive disorder. 2020.
25. Schaakxs R, Comijs HC, Lamers F, Beekman AT, Penninx BW. Age-related variability in the presentation of symptoms of major depressive disorder. Psychol Med. 2017;47(3):543-52. [DOI:10.1017/S0033291716002579] [PMID]
26. Hage MP, Azar STJJotr. The link between thyroid function and depression. 2012;2012(1):590648. [DOI:10.1155/2012/590648] [PMID] []
27. Samuels MH, Bernstein LJJT. Brain fog in hypothyroidism: what is it, how is it measured, and what can be done about it. 2022;32(7):752-63. [DOI:10.1089/thy.2022.0139] [PMID] []
28. Health UDo, Services H. Major depression. National Institute of Mental Health. 2022.
29. Sabic D, Sabic A, Bacic-Becirovic AJMs-m. Major depressive disorder and difference between genders. 2021;33(2):105. [DOI:10.5455/msm.2021.33.105-108] [PMID] []
30. Kverno KS, Mangano E. Treatment-Resistant Depression: Approaches to Treatment. J Psychosoc Nurs Ment Health Serv. 2021;59(9):7-11. [DOI:10.3928/02793695-20210816-01] [PMID]
31. Cuijpers P, Quero S, Dowrick C, Arroll B. Psychological Treatment of Depression in Primary Care: Recent Developments. Curr Psychiatry Rep. 2019;21(12):129. [DOI:10.1007/s11920-019-1117-x] [PMID] []
32. Tong AC, Ho FS, Chu OH, Mak WWJJoMIR. Time-dependent changes in depressive symptoms among control participants in digital-based psychological intervention studies: Meta-analysis of randomized controlled trials. 2023;25(1):e39029. [DOI:10.2196/39029] [PMID] []
33. Otto MW, Birk JL, Fitzgerald HE, Chauvin GV, Gold AK, Carl JR. Stage models for major depression: Cognitive behavior therapy, mechanistic treatment targets, and the prevention of stage transition. Clin Psychol Rev. 2022;95:102172. [DOI:10.1016/j.cpr.2022.102172] [PMID] []
34. Buoli M, Cumerlato Melter C, Caldiroli A, Altamura AC. Are antidepressants equally effective in the long-term treatment of major depressive disorder? Hum Psychopharmacol. 2015;30(1):21-7. [DOI:10.1002/hup.2447] [PMID]
35. Tarzian M, Ndrio M, Fakoya AO. An Introduction and Brief Overview of Psychoanalysis. Cureus. 2023;15(9):e45171. [DOI:10.7759/cureus.45171]
36. Varghese M, Kirpekar V, Loganathan S. Family Interventions: Basic Principles and Techniques. Indian J Psychiatry. 2020;62(Suppl 2):S192-S200. [DOI:10.4103/psychiatry.IndianJPsychiatry_770_19] [PMID] []
37. Toussaint L, Nguyen QA, Roettger C, Dixon K, Offenbacher M, Kohls N, et al. Effectiveness of Progressive Muscle Relaxation, Deep Breathing, and Guided Imagery in Promoting Psychological and Physiological States of Relaxation. Evid Based Complement Alternat Med. 2021;2021(1):5924040. [DOI:10.1155/2021/5924040] [PMID] []
38. Jia Y, Wang X, Cheng Y. Relaxation Therapy for Depression: An Updated Meta-analysis. J Nerv Ment Dis. 2020;208(4):319-28. [DOI:10.1097/NMD.0000000000001121] [PMID]
39. Yrondi A, Brauge D, LeMen J, Arbus C, Pariente J. Depression and sports-related concussion: A systematic review. Presse Med. 2017;46(10):890-902. [DOI:10.1016/j.lpm.2017.08.013] [PMID]
40. Blumenthal JA, Rozanski AJPicd. Exercise as a therapeutic modality for the prevention and treatment of depression. 2023;77:50-8. [DOI:10.1016/j.pcad.2023.02.008] [PMID] []
41. Steinmetz L, Simon L, Feige B, Riemann D, Akram U, Crawford MR, et al. Adherence to sleep restriction therapy-An evaluation of existing measures. 2023;32(6):e13975. [DOI:10.1111/jsr.13975] [PMID]
42. Vawda D. ANAESTHESIA FOR ELECTROCONVULSIVE THERAPY. 2023.
43. Hollon SD, Cohen ZD, Singla DR, Andrews PW. Recent Developments in the Treatment of Depression. Behav Ther. 2019;50(2):257-69. [DOI:10.1016/j.beth.2019.01.002] [PMID]
44. Cuijpers P, Stringaris A, Wolpert M. Treatment outcomes for depression: challenges and opportunities. Lancet Psychiatry. 2020;7(11):925-7. [DOI:10.1016/S2215-0366(20)30036-5] [PMID]
45. Bertani DE, De Novellis AMP, Farina R, Latella E, Meloni M, Scala C, et al. "shedding light on light": A review on the effects on mental health of exposure to optical radiation. 2021;18(4):1670. [DOI:10.3390/ijerph18041670] [PMID] []
46. O'Hagan J, Khazova M. Assessment of personal exposures to non-laser optical radiation in entertainment: Health Protection Agency; 2011.
47. Slominski AT, Zmijewski MA, Plonka PM, Szaflarski JP, Paus RJE. How UV light touches the brain and endocrine system through skin, and why. 2018;159(5):1992-2007. [DOI:10.1210/en.2017-03230] [PMID] []
48. Fan B, Zhang C, Chi J, Liang Y, Bao X, Cong Y, et al. The Molecular Mechanism of Retina Light Injury Focusing on Damage from Short Wavelength Light. Oxid Med Cell Longev. 2022;2022(1):8482149. [DOI:10.1155/2022/8482149] [PMID] []
49. Emiliani V, Entcheva E, Hedrich R, Hegemann P, Konrad KR, Luscher C, et al. Optogenetics for light control of biological systems. Nat Rev Methods Primers. 2022;2(1):55. [DOI:10.1038/s43586-022-00136-4] [PMID] []
50. Schnapf JL, Baylor DAJSA. How photoreceptor cells respond to light. 1987;256(4):40-7. [DOI:10.1038/scientificamerican0487-40] [PMID]
51. Ishikawa M, Sawada Y, Yoshitomi T. Structure and function of the interphotoreceptor matrix surrounding retinal photoreceptor cells. Exp Eye Res. 2015;133:3-18. [DOI:10.1016/j.exer.2015.02.017] [PMID]
52. Ayyar VS, Sukumaran S. Circadian rhythms: influence on physiology, pharmacology, and therapeutic interventions. J Pharmacokinet Pharmacodyn. 2021;48(3):321-38. [DOI:10.1007/s10928-021-09751-2] [PMID] []
53. Mure LS. Intrinsically Photosensitive Retinal Ganglion Cells of the Human Retina. Front Neurol. 2021;12:636330. [DOI:10.3389/fneur.2021.636330] [PMID] []
54. Herzog ED, Hermanstyne T, Smyllie NJ, Hastings MHJCSHpib. Regulating the suprachiasmatic nucleus (SCN) circadian clockwork: interplay between cell-autonomous and circuit-level mechanisms. 2017;9(1):a027706. [DOI:10.1101/cshperspect.a027706] [PMID] []
55. Daut RA, Fonken LK. Circadian regulation of depression: A role for serotonin. Front Neuroendocrinol. 2019;54:100746. [DOI:10.1016/j.yfrne.2019.04.003] [PMID] []
56. Rahman SA, St Hilaire MA, Gronfier C, Chang AM, Santhi N, Czeisler CA, et al. Functional decoupling of melatonin suppression and circadian phase resetting in humans. J Physiol. 2018;596(11):2147-57. [DOI:10.1113/JP275501] [PMID] []
57. McGlashan EM, Nandam LS, Vidafar P, Mansfield DR, Rajaratnam SMW, Cain SW. The SSRI citalopram increases the sensitivity of the human circadian system to light in an acute dose. Psychopharmacology (Berl). 2018;235(11):3201-9. [DOI:10.1007/s00213-018-5019-0] [PMID]
58. Melrose S. Seasonal Affective Disorder: An Overview of Assessment and Treatment Approaches. Depress Res Treat. 2015;2015(1):178564. [DOI:10.1155/2015/178564] [PMID] []
59. Ishihara A, Courville A, Chen K. The complex effects of light on metabolism in humans. Nutrients. 2023; 15 (6): 1391. [DOI:10.3390/nu15061391] [PMID] []
60. Bahrami M, Cheraghpour M, Jafarirad S, Alavinejad P, Asadi F, Hekmatdoost A, et al. The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial. Complement Ther Med. 2020;52:102452. [DOI:10.1016/j.ctim.2020.102452] [PMID]
61. Pivonello C, Negri M, Patalano R, Amatrudo F, Monto T, Liccardi A, et al. The role of melatonin in the molecular mechanisms underlying metaflammation and infections in obesity: A narrative review. Obes Rev. 2022;23(3):e13390. [DOI:10.1111/obr.13390] [PMID] []
62. Huang C, Zhang C, Cao Y, Li J, Bi F. Major roles of the circadian clock in cancer. Cancer Biol Med. 2023;20(1):1-24.
https://doi.org/10.20892/j.issn.2095-3941.2022.0474 [DOI:10.20892/j.issn.2095-3941.2023.0278] [PMID] []
63. Ball LJ, Palesh O, Kriegsfeld LJ. The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis. Endocr Rev. 2016;37(5):450-66. [DOI:10.1210/er.2015-1133] [PMID] []
64. Li Y, Li S, Zhou Y, Meng X, Zhang JJ, Xu DP, et al. Melatonin for the prevention and treatment of cancer. Oncotarget. 2017;8(24):39896-921. [DOI:10.18632/oncotarget.16379] [PMID] []
65. Paul S, Brown TM. Direct effects of the light environment on daily neuroendocrine control. J Endocrinol. 2019;243(1):R1-R18. [DOI:10.1530/JOE-19-0302] [PMID]
66. Zisapel NJBjop. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. 2018;175(16):3190-9. [DOI:10.1111/bph.14116] [PMID] []
67. Mohd Azmi NAS, Juliana N, Azmani S, Mohd Effendy N, Abu IF, Mohd Fahmi Teng NI, et al. Cortisol on Circadian Rhythm and Its Effect on Cardiovascular System. Int J Environ Res Public Health. 2021;18(2):676. [DOI:10.3390/ijerph18020676] [PMID] []
68. Stefaniak M, Dmoch-Gajzlerska E, Jankowska K, Rogowski A, Kajdy A, Maksym RB. Progesterone and Its Metabolites Play a Beneficial Role in Affect Regulation in the Female Brain. Pharmaceuticals (Basel). 2023;16(4):520. [DOI:10.3390/ph16040520] [PMID] []
69. Korać RR, Khambholja KMJPr. Potential of herbs in skin protection from ultraviolet radiation. 2011;5(10):164. [DOI:10.4103/0973-7847.91114] [PMID] []
70. Bikle D. Vitamin D: production, metabolism, and mechanisms of action. MDText. com. Inc; 2017.
71. Slominski AT, Brozyna AA, Zmijewski MA, Jozwicki W, Jetten AM, Mason RS, et al. Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management. Lab Invest. 2017;97(6):706-24. [DOI:10.1038/labinvest.2017.3] [PMID] []
72. Juzeniene A, Moan JJD-e. Beneficial effects of UV radiation other than via vitamin D production. 2012;4(2):109-17. [DOI:10.4161/derm.20013] [PMID] []
73. Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol Metab Clin North Am. 2010;39(2):255-69, table of contents. [DOI:10.1016/j.ecl.2010.02.007] [PMID] []
74. Thiel A, Hermanns C, Lauer AA, Reichrath J, Erhardt T, Hartmann T, et al. Vitamin D and its analogues: from differences in molecular mechanisms to potential benefits of adapted use in the treatment of Alzheimer's disease. 2023;15(7):1684. [DOI:10.3390/nu15071684] [PMID] []
75. Sailike B, Onzhanova Z, Akbay B, Tokay T, Molnar F. Vitamin D in Central Nervous System: Implications for Neurological Disorders. Int J Mol Sci. 2024;25(14):7809. [DOI:10.3390/ijms25147809] [PMID] []
76. Ahmad SB, Ali A, Bilal M, Rashid SM, Wani AB, Bhat RR, et al. Melatonin and Health: Insights of Melatonin Action, Biological Functions, and Associated Disorders. Cell Mol Neurobiol. 2023;43(6):2437-58. [DOI:10.1007/s10571-023-01324-w] [PMID] []
77. Hwang OJ, Back K. Functional Characterization of Arylalkylamine N-Acetyltransferase, a Pivotal Gene in Antioxidant Melatonin Biosynthesis from Chlamydomonas reinhardtii. Antioxidants (Basel). 2022;11(8):1531. [DOI:10.3390/antiox11081531] [PMID] []
78. Smith MR, Revell VL, Eastman CI. Phase advancing the human circadian clock with blue-enriched polychromatic light. Sleep Med. 2009;10(3):287-94. [DOI:10.1016/j.sleep.2008.05.005] [PMID] []
79. Lam RW, Teng MY, Jung YE, Evans VC, Gottlieb JF, Chakrabarty T, et al. Light Therapy for Patients With Bipolar Depression: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Can J Psychiatry. 2020;65(5):290-300. [DOI:10.1177/0706743719892471] [PMID] []
80. Terman JS, Terman M, Lo ES, Cooper TB. Circadian time of morning light administration and therapeutic response in winter depression. Arch Gen Psychiatry. 2001;58(1):69-75. [DOI:10.1001/archpsyc.58.1.69] [PMID]
81. Dermanowski MM, Wichniak A, Hejduk A, Kuczynska J, Dominiak M, Mierzejewski P. Behavioural Parameters of Circadian Rhythm Are Not Correlated with Dim Light Melatonin Onset: An Observational Study on Healthy Volunteers. J Clin Med. 2023;12(24):7757. [DOI:10.3390/jcm12247757] [PMID] []
82. Campbell PD, Miller AM, Woesner ME. Bright Light Therapy: Seasonal Affective Disorder and Beyond. Einstein J Biol Med. 2017;32:E13-E25.
83. Reeves GM, Nijjar GV, Langenberg P, Johnson MA, Khabazghazvini B, Sleemi A, et al. Improvement in depression scores after 1 hour of light therapy treatment in patients with seasonal affective disorder. J Nerv Ment Dis. 2012;200(1):51-5. [DOI:10.1097/NMD.0b013e31823e56ca] [PMID] []
84. Ghaznavi S, Deckersbach T. Rumination in bipolar disorder: Evidence for an unquiet mind. Biology of Mood & Anxiety Disorders, 2, 2-11. 2012. [DOI:10.1186/2045-5380-2-2] [PMID] []
85. Shelton RCJHoPP. Mood Stabilizers. 2024:303.
86. Savarese M, Di Perri MC. Excessive sleepiness in shift work disorder: a narrative review of the last 5 years. Sleep Breath. 2020;24(1):297-310. [DOI:10.1007/s11325-019-01925-0] [PMID]
87. Aan Het Rot M, Miloserdov K, Buijze ALF, Meesters Y, Gordijn MCM. Premenstrual mood and empathy after a single light therapy session. Psychiatry Res. 2017;256:212-8. [DOI:10.1016/j.psychres.2017.06.052] [PMID]
88. AlBreiki M, Middleton B, Ebajemito J, Hampton SJPotNS. The effect of light on appetite in healthy young individuals. 2015;74(OCE1):E4. [DOI:10.1017/S0029665115000191]
89. Fargason RE, Fobian AD, Hablitz LM, Paul JR, White BA, Cropsey KL, et al. Correcting delayed circadian phase with bright light therapy predicts improvement in ADHD symptoms: A pilot study. J Psychiatr Res. 2017;91:105-10. [DOI:10.1016/j.jpsychires.2017.03.004] [PMID] []
90. Mussttaf RA, Jenkins DFL, Jha AN. Assessing the impact of low level laser therapy (LLLT) on biological systems: a review. Int J Radiat Biol. 2019;95(2):120-43. [DOI:10.1080/09553002.2019.1524944] [PMID]
91. Yousefi-Nooraie R, Schonstein E, Heidari K, Rashidian A, Pennick V, Akbari-Kamrani M, et al. Low level laser therapy for nonspecific low-back pain. Cochrane Database Syst Rev. 2008;2008(2):CD005107. [DOI:10.1002/14651858.CD005107.pub4] [PMID] []
92. Cotler HB, Chow RT, Hamblin MR, Carroll J. The Use of Low Level Laser Therapy (LLLT) For Musculoskeletal Pain. MOJ Orthop Rheumatol. 2015;2(5). [DOI:10.15406/mojor.2015.02.00068] [PMID] []
93. Naderi MS, Razzaghi M, Esmaeeli Djavid G, Hajebrahimi Z. A Comparative Study of 660 nm Low-Level Laser and Light Emitted Diode in Proliferative Effects of Fibroblast Cells. J Lasers Med Sci. 2017;8(Suppl 1):S46-S50. [DOI:10.15171/jlms.2017.s9] [PMID] []
94. Naderi MS, Tabaie SM, Pornour MJJoLiM. Increasing the Viability of the Rat Hair Follicle Stem Cells with Low-level Laser Irradiation. 2020;17(2):7-2.
95. Naderi MS, Tabaie SM, Soheilifar MH, Pornour MJTUoMSJ. Evaluation of the effect of low-level laser irradiation on viability and ROS production in human hair follicle stem cells. 2021;79(1):26-32.
96. Naderi MS, Tabayi SM. Study of Proliferation of Mesenchymal Stem cells under carboxy therapy and low-level laser. 2023.
97. Klein DN, Goldstein BL, Finsaas MJC, Adolescent Psychopathology TE. Depressive disorders. 2017:610-41. [DOI:10.1002/9781394258932.ch18] [PMID] []
98. Cui L, Li S, Wang S, Wu X, Liu Y, Yu W, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther. 2024;9(1):30. [DOI:10.1038/s41392-024-01738-y] [PMID] []
99. Shajib MS, Khan WI. The role of serotonin and its receptors in activation of immune responses and inflammation. Acta Physiol (Oxf). 2015;213(3):561-74. [DOI:10.1111/apha.12430] [PMID]
100. Jiang M, Wang L, Sheng H. Mitochondria in depression: The dysfunction of mitochondrial energy metabolism and quality control systems. CNS Neurosci Ther. 2024;30(2):e14576. [DOI:10.1111/cns.14576] [PMID] []
101. Bansal Y, Kuhad A. Mitochondrial Dysfunction in Depression. Curr Neuropharmacol. 2016;14(6):610-8. [DOI:10.2174/1570159X14666160229114755] [PMID] []
102. Tim CR, Bossini PS, Kido HW, Malavazi I, von Zeska Kress MR, Carazzolle MF, et al. Effects of low level laser therapy on inflammatory and angiogenic gene expression during the process of bone healing: A microarray analysis. J Photochem Photobiol B. 2016;154:8-15. [DOI:10.1016/j.jphotobiol.2015.10.028] [PMID]
103. Ferraresi C, Kaippert B, Avci P, Huang YY, De Sousa MV, Bagnato VS, et al. Low‐level laser (light) therapy increases mitochondrial membrane potential and ATP synthesis in C2C12 myotubes with a peak response at 3-6 h. 2015;91(2):411-6. [DOI:10.1111/php.12397] [PMID] []
104. Lapchak PA, Butte P, Rajput PS. Difficult Path to Treating Acute Ischemic Stroke Patients with Transcranial Near-Infrared Laser Therapy. Handbook of Low-Level Laser Therapy: Jenny Stanford Publishing; 2016. p. 777-96. [DOI:10.1201/9781315364827-39]
105. Meng F, Wang J, Wang L, Zou W. Glucose metabolism impairment in major depressive disorder. Brain Res Bull. 2025;221:111191. [DOI:10.1016/j.brainresbull.2025.111191] [PMID]
106. Souza NH, Ferrari RA, Silva DF, Nunes FD, Bussadori SK, Fernandes KP. Effect of low-level laser therapy on the modulation of the mitochondrial activity of macrophages. Braz J Phys Ther. 2014;18(4):308-14. [DOI:10.1590/bjpt-rbf.2014.0046] [PMID] []
107. Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry. 2007;64(3):327-37. [DOI:10.1001/archpsyc.64.3.327] [PMID]
108. Belujon P, Grace AA. Dopamine System Dysregulation in Major Depressive Disorders. Int J Neuropsychopharmacol. 2017;20(12):1036-46. [DOI:10.1093/ijnp/pyx056] [PMID] []
109. Clemente-Suárez VJ, Redondo-Flórez L, Beltrán-Velasco AI, Ramos-Campo DJ, Belinchón-deMiguel P, Martinez-Guardado I, et al. Mitochondria and brain disease: a comprehensive review of pathological mechanisms and therapeutic opportunities. 2023;11(9):2488. [DOI:10.3390/biomedicines11092488] [PMID] []
110. Watson SA, McStay GP. Functions of Cytochrome c oxidase Assembly Factors. Int J Mol Sci. 2020;21(19):7254. [DOI:10.3390/ijms21197254] [PMID] []
111. Rola P, Włodarczak S, Lesiak M, Doroszko A, Włodarczak A, editors. Changes in cell biology under the influence of low-level laser therapy. Photonics; 2022: MDPI. [DOI:10.3390/photonics9070502]
112. Farivar S, Malekshahabi T, Shiari R. Biological effects of low level laser therapy. J Lasers Med Sci. 2014;5(2):58-62.
113. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552(Pt 2):335-44. [DOI:10.1113/jphysiol.2003.049478] [PMID] []
114. Hashmi JT, Huang YY, Osmani BZ, Sharma SK, Naeser MA, Hamblin MR. Role of low-level laser therapy in neurorehabilitation. PM R. 2010;2(12 Suppl 2):S292-305. [DOI:10.1016/j.pmrj.2010.10.013] [PMID] []
115. Kheradmand A, Donboli S, Tanjani PT, Farhadinasab A, Tabeie F, Qutbi M, et al. Therapeutic Effects of Low-Level Laser Therapy on Cognitive Symptoms of Patients with Dementia: A Double-Blinded Randomized Clinical Trial. Photobiomodul Photomed Laser Surg. 2022;40(9):632-8. [DOI:10.1089/photob.2021.0135] [PMID]
116. Farfara D, Tuby H, Trudler D, Doron-Mandel E, Maltz L, Vassar RJ, et al. Low-level laser therapy ameliorates disease progression in a mouse model of Alzheimer's disease. 2015;55:430-6. [DOI:10.1007/s12031-014-0354-z] [PMID]
117. Xu Z, Guo X, Yang Y, Tucker D, Lu Y, Xin N, et al. Low-Level Laser Irradiation Improves Depression-Like Behaviors in Mice. Mol Neurobiol. 2017;54(6):4551-9. [DOI:10.1007/s12035-016-9983-2] [PMID] []
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |